|
Market Closed -
London S.E.
11:35:19 2026-08-25 am EDT
|
5-day change | 1st Jan Change | ||
| 1,905.50 GBX | +0.79% |
|
+0.93% | +4.44% |
| 03:50am | GSK plc : Deutsche Bank remains Neutral | ZD |
| Aug. 24 | FTSE 100 outperforms as oil price heads lower | AN |
| Market Cap | 75.75B 103B 88.51B 82.93B 143B 9,847B 144B 978B 381B 4,968B 388B 379B 16,452B | P/E 2026 * |
14.3x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 95.59B 130B 112B 105B 180B 12,425B 182B 1,234B 481B 6,269B 489B 479B 20,760B | EV / Sales 2026 * |
2.82x | EV / Sales 2027 * | 2.61x |
| Free-Float |
92.75% | Yield 2026 * |
3.68% | Yield 2027 * | 3.96% |
Last Transcript: GSK plc
| 03:50am | GSK plc : Deutsche Bank remains Neutral | ZD |
| Aug. 20 | Cancer vaccines finally garner the spotlight |  |
| Aug. 19 | GSK plc : Deutsche Bank remains Neutral | ZD |
| Aug. 17 | GSK Kept at Hold as Berenberg Notes Cost Savings Plan | MT |
| Aug. 17 | GSK plc : Berenberg gives a Neutral rating | ZD |
| 1 day | +1.04% | ||
| 1 week | +0.93% | ||
| Current month | -1.35% | ||
| 1 month | -2.83% | ||
| 3 months | -1.01% | ||
| 6 months | -13.93% | ||
| Current year | +4.44% |
| 1 week | 1,868.5 |  | 1,937 |
| 1 month | 1,803 | | 2,096 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,440.29 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | 52 | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
James Ford
CMP | Compliance Officer | - | 2018-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | 52 | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 67 | 2019-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/29/26 | Sell | Executive/Senior Manager | -38,000 | 0.0009% | ||
| 7/22/26 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 7/14/26 | Buy | Chief Technology Officer | 660 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.79% | +0.93% | +29.67% | +38.68% | 103B | |
| -0.66% | +1.10% | +78.22% | +123.83% | 1,111B | |
| +0.66% | +0.78% | +53.15% | +64.35% | 658B | |
| +0.68% | +2.86% | +28.31% | +81.55% | 467B | |
| +0.92% | +3.57% | +43.82% | +44.21% | 369B | |
| +1.25% | +2.21% | +26.77% | +43.05% | 301B | |
| +3.02% | +5.68% | +5.09% | +17.04% | 256B | |
| +0.02% | +4.40% | +53.91% | +73.18% | 240B | |
| +2.86% | +3.86% | -16.20% | -51.83% | 207B | |
| +1.36% | +3.53% | +30.09% | +93.21% | 182B | |
| Average | +1.13% | +4.25% | +33.28% | +52.73% | 389.44B | |
| Weighted average by Cap. | +0.65% | +4.61% | +45.91% | +71.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.94B 46.27B 39.65B 37.15B 64.05B 4,411B 64.68B 438B 171B 2,226B 174B 170B 7,370B | 35.52B 48.42B 41.49B 38.88B 67.03B 4,616B 67.69B 459B 179B 2,329B 182B 178B 7,713B |
| Net income | 5.44B 7.41B 6.35B 5.95B 10.26B 707B 10.36B 70.19B 27.33B 356B 27.83B 27.22B 1,181B | 6.48B 8.84B 7.58B 7.1B 12.24B 843B 12.36B 83.73B 32.6B 425B 33.2B 32.47B 1,408B |
| Net Debt | 19.84B 27.05B 23.18B 21.72B 37.44B 2,579B 37.81B 256B 99.73B 1,301B 102B 99.35B 4,308B | 17.06B 23.26B 19.93B 18.68B 32.2B 2,218B 32.51B 220B 85.76B 1,119B 87.34B 85.44B 3,705B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-25 | GBX 1,905.50 | +0.79% | 3,250,673 |
| 26-08-24 | GBX 1,890.50 | -1.46% | 5,275,639 |
| 26-08-21 | GBX 1,918.50 | -0.10% | 4,820,018 |
| 26-08-20 | GBX 1,920.50 | +0.23% | 8,381,344 |
| 26-08-19 | GBX 1,916.00 | +1.48% | 4,490,573 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
